Insider Transactions

What Myovant Sciences Ltd.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	0
Sells	0	0
Total trades	0	0

Shares traded

	3 months	12 months
Acquired	0	0
Disposed	0	0
Net activity	+0	+0

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Lang Matthew	General Counsel & Corp. Secy.	Mar 10	Disposition to Issuer · D	−241,158	—	—	0
Lang Matthew	General Counsel & Corp. Secy.	Mar 10	Disposition to Issuer · D	−113,145	—	—	241,158
Potter Myrtle S	Director	Mar 10	Disposition to Issuer · D	−3,673	—	—	0
Arjona Ferreira Juan Camilo	Chief Medical Officer	Mar 10	Disposition to Issuer · D	−86,602	—	—	160,082
Arjona Ferreira Juan Camilo	Chief Medical Officer	Mar 10	Disposition to Issuer · D	−160,082	—	—	0
Gulfo Adele M.	Director	Mar 10	Disposition to Issuer · D	−3,673	—	—	0
Curran Terrie	Director	Mar 10	Disposition to Issuer · D	−3,673	—	—	0
Sumitomo Chemical Co., Ltd.	10% owner	Mar 10	Open-market buy · P	+51,599,200	$27.00	+$1.39B	45,798,176
Merendino Lauren	Chief Commercial Officer	Mar 10	Disposition to Issuer · D	−147,747	—	—	0
Merendino Lauren	Chief Commercial Officer	Mar 10	Disposition to Issuer · D	−21,791	—	—	147,747
Mehra Uneek	Principal Financial Officer	Mar 10	Disposition to Issuer · D	−181,972	—	—	0
Mehra Uneek	Principal Financial Officer	Mar 10	Disposition to Issuer · D	−20,724	—	—	181,972
Marek David C	Principal Executive Officer	Mar 10	Disposition to Issuer · D	−321,924	—	—	0
Marek David C	Principal Executive Officer	Mar 10	Disposition to Issuer · D	−95,675	—	—	321,924
Valente Nancy	Director	Mar 10	Disposition to Issuer · D	−3,673	—	—	0
Guinan Mark	Director	Mar 10	Disposition to Issuer · D	−3,673	—	—	0
Sumitomo Chemical Co., Ltd.	10% owner	Mar 03	Other Transaction · J	−4,243,005	—	—	45,798,176
Lang Matthew	General Counsel & Corp. Secy.	Jan 18	Sale for tax withholding · S	−1,272	$26.89	−$34.2K	354,303
Arjona Ferreira Juan Camilo	Chief Medical Officer	Jan 18	Sale for tax withholding · S	−1,109	$26.89	−$29.8K	246,684
Merendino Lauren	Chief Commercial Officer	Jan 18	Sale for tax withholding · S	−2,008	$26.89	−$54K	169,538

Page 1 of 16 · showing the 20 most recent Sign up free to view all 318 transactions and filter by insider →

Comments